Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia

NCT07014449 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

AML (Acute Myelogenous Leukemia
Relapsed Acute Myelogenous Leukemia
Refractory Acute Myeloid Leukemia
Hematologic Malignancy
C-Myc
Adult Acute Myeloid Leukemia

Interventions

DRUG: WBC100 QD

Sponsor

Hangzhou Weben Pharma Co., Ltd